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Background: Hypercortisolism leads to various physical, psychological and cognitive symptoms, which may
partly persist after the treatment of Cushing's disease. The aim of the present study was to investigate ab-
normalities inwhitematter integrity in patients with long-term remission of Cushing's disease, and their relation
with psychological symptoms, cognitive impairment and clinical characteristics.
Methods: In patients with long-term remission of Cushing's disease (n= 22) andmatched healthy controls (n=
22) we examined fractional anisotropy (FA) values of white matter in a region-of-interest (ROI; bilateral
cingulate cingulum, bilateral hippocampal cingulum, bilateral uncinate fasciculus and corpus callosum) and
the whole brain, using 3 T diffusion tensor imaging (DTI) and a tract-based spatial statistics (TBSS) approach.
Psychological and cognitive functioning were assessed with validated questionnaires and clinical severity was
assessed using the Cushing's syndrome Severity Index.
Results: The ROI analysis showed FA reductions in all of the hypothesized regions, with the exception of
the bilateral hippocampal cingulum, in patients when compared to controls. The exploratory whole brain
analysis showed multiple regions with lower FA values throughout the brain. Patients reported more apathy
(p = .003) and more depressive symptoms (p b .001), whereas depression symptom severity in the patient
group was negatively associated with FA in the left uncinate fasciculus (p b 0.05). Post-hoc analyses showed
increased radial and mean diffusivity in the patient group.
Conclusion: Patients with a history of endogenous hypercortisolism in present remission show widespread
changes of white matter integrity in the brain, with abnormalities in the integrity of the uncinate fasciculus
being related to the severity of depressive symptoms, suggesting persistent structural effects of hypercortisolism.
© 2014 The Authors. The Authors. Published by Elsevier Inc. All rights reserved. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Cushing's disease is caused by an adrenocorticotropic hormone
(ACTH) producing pituitary adenoma, which in turn causes hyper-
cortisolism (Nieman and Ilias, 2005). Hypercortisolism is associated
with severe physical and psychological symptoms and cognitive impair-
ments (Forget et al., 2000; Leon-Carrion et al., 2009; Michaud et al.,
2009; Newell-Price et al., 2006; Nieman and Ilias, 2005). Patients withry, Leiden University Medical
el.: +31 71 526 2281.
n der Werff).
ship.
lished by Elsevier Inc. All righCushing's disease are treated by undergoing surgery, in some cases
followed by postoperative radiotherapy and/or hydrocortisone substi-
tution, dependent on the outcome of the surgery. Remission occurs
with the re-instatement of normalized basal and ACTH-stimulated cor-
tisol values. Although the clinical picture improves substantially after
the successful treatment of hypercortisolism (Starkman et al., 1986),
various symptoms remain present during long-term remission. Com-
pared to healthy controls, patients treated for Cushing's disease demon-
strated more cognitive impairment (Dorn and Cerrone, 2000; Forget
et al., 2002; Merke et al., 2005; Resmini et al., 2012; Tiemensma et al.,
2010b), more quality of life impairments (Tiemensma et al., 2011; van
Aken et al., 2005), a higher prevalence of psychopathology (e.g. affective
disorders and apathy; (Tiemensma et al., 2010a) and maladaptivets reserved. This is an open access article under the CC BY-NC-ND license
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toms following transient hypercortisolism are not well understood.
Neuroimaging studies investigating brain characteristics related to
(a history of) Cushing's disease are scarce, and the few studies examin-
ing structural brain characteristics have mainly focused on gray matter
volumes. Hypercortisolismwas found to be associatedwith smaller hip-
pocampal volumes and overall brain atrophy (Bourdeau et al., 2002;
Simmons et al., 2000; Starkman et al., 1992). After an early successful
abrogation of hypercortisolism, hippocampal volume increased and
emotional and cognitive functioning improved (Bourdeau et al., 2002;
Hook et al., 2007; Starkman et al., 1999, 2003; Toffanin et al., 2011). Pa-
tients with remission of Cushing's disease demonstrated no differences
in hippocampal volume compared to controls (Andela et al., 2013;
Resmini et al., 2012; Starkman et al., 1999). However, smaller gray
matter volumes in the anterior cingulate cortex (ACC) and larger gray
matter volumes of the left posterior lobe of the cerebellum have been
shown in patients with remission of Cushing's disease (Andela et al.,
2013). Interestingly, both the hippocampus and ACC are involved in
the functional neurocircuitry of stress (Dedovic et al., 2009),with subre-
gions of the ACC having an inhibitory effect on various limbic structures
(Baumann and Turpin, 2010; Phelps et al., 2004). Disturbances in this
inhibitory function resulted in the dysregulation of emotion and im-
paired cognition in affective disorders (Phan et al., 2005; Shin and
Liberzon, 2010). In this light, studying the structural connectivity be-
tween these brain regions in patients with long-term remission of
hypercortisolism could give further insight into the pathophysiology
of persistent psychological symptoms and cognitive impairment.
White matter integrity has never been studied in Cushing's disease,
and the relationship between white matter and elevated cortisol levels
has only been studied in animal models (Alonso, 2000; Miyata et al.,
2011; Willette et al., 2012). These studies showed an association be-
tween the prolonged exposure to elevated corticosteroid levels and
the inhibition of the proliferation of oligodendrocyte precursors
throughout the white matter. Oligodendrocytes play a major role in
the process of remyelination, and thus white matter integrity (Alonso,
2000; Miyata et al., 2011). In addition, studies examining white matter
in stress-related psychiatric disorders (depressive disorders, anxiety
disorders and posttraumatic stress disorder) are of interest because
these disorders are often accompanied by an unbalanced hypothalam-
ic–pituitary–adrenal axis, resulting in increased levels of cortisol, as
well as psychiatric symptoms similar to those reported by Cushing's dis-
ease patients. Stress-related psychiatric disorders have been related to
reduced white matter integrity in mainly the corpus callosum, the cin-
gulum and the uncinate fasciculus (Cullen et al., 2010; Eluvathingal
et al., 2006; Jackowski et al., 2008; Kieseppa et al., 2010; Schuff et al.,
2011; Sexton et al., 2009; Villarreal et al., 2004).
In the present studywe examinedwhitematter integrity bymeasur-
ing fractional anisotropy (FA) in patients with long-term remission of
Cushing's disease and matched healthy controls. FA reﬂects the degree
of diffusion directionality and is a sensitive marker of the tissue micro-
structural organization (Alexander et al., 2007; Hasan et al., 2004).
Lower FA values are associated with decreased white matter integrity.
However, as FA is a non-speciﬁc marker for white matter integrity, it
gives no information about the structural properties underlying abnor-
malities in white matter tissue. In order to interpret the differences in
FA, the mean diffusivity (MD) and the tensor regional eigenvalues
were also assessed. Decreased diffusion along the principal direction
of the ﬁber (axial diffusivity; AD) indicates axonal loss (Budde et al.,
2009),while increased diffusion perpendicular to theprincipal direction
of the ﬁber (Radial Diffusivity; RD) indicates demyelination (Alexander
et al., 2007; Song et al., 2002, 2005). In addition, an increase in overall
water diffusion in all directions (MD) is also an indication for demyelin-
ation (Horsﬁeld and Jones, 2002), but could be caused by the presence
of edema as well (Alexander et al., 2007).
Taking into account the previously identiﬁed graymatter abnormal-
ities and the ﬁndings of studies on stress-related disorders, wehypothesized lower FA values in patients with long-term remission
of Cushing's disease in a region-of-interest (ROI) including the cor-
pus callosum, the bilateral cingulate cingulum, the bilateral hippo-
campal cingulum, and the bilateral uncinate fasciculus. In addition,
we hypothesized that white matter abnormalities correlate with
psychological and cognitive functioning, as well as duration of re-
mission, disease duration and clinical severity. Furthermore, we
performed an explorative whole brain analysis to detect possible
changes in FA values in white matter outside our a priori deﬁned re-
gions of interest. Finally, to assess the nature of the white matter
abnormalities indicated by differences in FA, post-hoc analyses
are performed on the AD, RD, and MD.
2. Materials and methods
2.1. Subjects
All patients with remission of Cushing's disease of pituitary origin
monitored at our institute (n = 49) and between 18 and 60 years of
age, were invited by letter and those who did not respond were
contacted by phone. The response rate was 96%, 31 patients were will-
ing to participate and were screened for eligibility. 6 patients were ex-
cluded due to one of the following exclusion criteria: a (history of)
drug- or alcohol abuse, neurological problems, contraindications for
undergoing a magnetic resonance imaging (MRI) scan and left-
handedness. Healthy controls were pair-wise matched to the patients
on the variables gender, age, and education. They were recruited by
advertisements in grocery stores and via the Internet. In addition to
the general exclusion criteria of the study (a history of) psychiatric
disorders was an exclusion criterion for the control group.
A total of 25 patients with remission of Cushing's disease and 25
matched healthy controls were included in this study. In the data
analysis process, we decided to further exclude the data of 3 patients
and their matched controls due to insufﬁcient quality of the diffusion
tensor imaging (DTI) data, resulting in a ﬁnal sample of 22 patients
and 22 matched controls.
The diagnosis of Cushing's disease had been conﬁrmed in all patients,
following previously described criteria (Tiemensma et al., 2010b). Some
patients remained glucocorticoid dependent after surgery and were
substituted with hydrocortisone (on average 20 mg/day, divided into
three dosages). The estimated duration of disease was determined
through patients' history by looking for the earliest physical/somatic
signs. Duration of remission was calculated from the date of curative
transsphenoidal surgery, or in case of persistent disease, from the date
of normalization of biochemical tests after postoperative radiotherapy.
Demographics and patient characteristics are reported in Table 1.
Written informed consent was obtained from all participants prior to
the clinical assessment and the MRI-scan session. The medical ethical
committee of the Leiden University Medical Center approved the
study protocol.
2.2. Education
The education level was classiﬁed following the Dutch education
system,which is comparable to the International Standard Classiﬁcation
of Education (ISCED). Low = primary education (elementary school)
and lower secondary education (preparatory secondary education);
intermediate = higher secondary education (higher general continued
education, pre-university secondary education) and post-secondary
education (intermediate vocational education); high = tertiary
education (higher professional education, university).
2.3. Study procedure
We scheduled a single study visit that consisted of approximately
two hours for MRI scanning (60 min), an interview for the evaluation
Table 1
Demographics of the total sample and clinical characteristics of the patients with long-term remission of Cushing's disease.
Characteristics Patients with long-term remission
of Cushing's disease (n = 22)
Matched healthy
controls (n = 22)
Gender (male/female) 4/18 4/18
Age (years), mean (S.D.) 44.42 (7.33) 46.42 (7.30)
Education, n (%)
Low 5 (22.7%) 5 (22.7%)
Intermediate 11 (50%) 10 (45.5%)
High 6 (27.3%) 7 (31.8%)
Surgery, n (%)
Transsphenoidal adenomectomy 22 (100%)
Bilateral adrenalectomy 2 (9.1%)
Radiotherapy, n (%) 5 (22.7%)
Disease duration (years), mean (S.D.) 6.73 (5.39)
Duration of remission (years), mean (S.D.) 11.87 (8.49)
Estimated age on onset (years), mean (S.D.) 25.81 (9.04)
Hypopituitarism, n (%)
Any axis 13 (59.1%)
GH 9 (40.9%)
LH/FSH 8 (36.4%)
TSH 9 (40.9%)
ADH 2 (9.1%)
Hydrocortisone substitution 12 (54.5%)
Clinical Severity Index (CSI), mean (S.D.)
Active phase, total 8.05 (1.96)
Remission phase, total 2.59 (1.50)
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functioning. After the scan session, participants were asked to complete
several self-rating questionnaires at home for the assessment of psycho-
pathology and cognitive functioning and to return themwithin a week.
2.4. Assessment of psychopathology and cognitive functioning
Presence and severity of depressive symptoms were evaluated
using the Montgomery–Åsberg Depression Rating Scale (MADRS;
Montgomery and Asberg, 1979; Snaith et al., 1986), which was the
only interviewer rated scale, and the Inventory of Depression Symptom-
atology (IDS; (Rush et al., 1996)). Anxiety was evaluated using the Beck
Anxiety Inventory (BAI; Beck et al., 1988) and the Fear Questionnaire
(FQ; Marks and Mathews, 1979). Apathy and irritability were assessed
using the Apathy Scale (AS) and the Irritability Scale (IS), respectively
(Chatterjee et al., 2005; Starkstein et al., 2001). The Cognitive Failures
Questionnaire (CFQ) was used to assess failures in perception, memory,
and motor function (Broadbent et al., 1982).
2.5. Cushing's syndrome Severity Index (CSI)
To assess clinical severity, the Cushing's syndrome Severity Index
(CSI; (Sonino et al., 2000)) was used for current severity of symptoms
and to retrospectively estimate (clinical) severity at the time of active
disease. The CSI contains eight clinical features and can be scored on a
3-point scale, ranging from 0 to 2. A higher total score on the CSI
indicates greater severity, with a range of 0–16. The information neces-
sary for completing this index was derived from clinical history and
medical ﬁles. Two raters, who reached consensus on each feature in
case of discrepancy, scored the CSI. For the active phase, the CSI was
scored retrospectively. The current score was evaluated based on the
last yearly evaluation. The total score of the active phase and the total
score of the remission phase were used in the analyses.
2.6. Data acquisition and preprocessing
DTI data were collected using a Philips 3.0 T Achieva MRI scanner
(Philips Medical Systems, Best, The Netherlands) with a 32-channel
SENSE (sensitivity encoding) head coil. A single-shot echo-planar imag-
ing sequence was used with the following scan parameters: repetitiontime = 6250 ms, echo time = 69 ms, ﬂip angle = 90°, b-factor =
1000 s/mm2, voxel dimensions = 2 mm isotropic, number of slices =
60, and no slice gap. DTI data were acquired along 32 directions, togeth-
er with a baseline image having no diffusion weighting (b = 0). Total
DTI scanning time was ~8 min. Collected DTI data were preprocessed
and analyzed using the Oxford Centre for Functional MRI of the Brain
(FMRIB) software library (FSL; http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/) ver-
sion 5.0.2. First, DTI data were corrected for distortion and motion arti-
facts induced by eddy currents or by simple head motions, using afﬁne
registration of each diffusion weighted image to the b = 0 reference
image. Next, non-brain tissue was removed using the Brain Extraction
Tool. Following, in order to generate individual FAmaps for each partic-
ipant, the diffusion tensor model was ﬁtted to each voxel using FMRIB's
diffusion toolbox.
2.7. Whole brain TBSS
Tractal based spatial statistics (TBSS) version 1.2 was used for
voxelwise analysis of the preprocessed FA data. First, individual FA im-
ages were aligned to the FMRIB58_FA standard-space image using non-
linear registration. Next, themean FA imagewas generated and thinned
to create a mean FA skeleton, which represents the centers of all tracts
common to the entire group. The mean FA skeleton was then
thresholded at a FA value of≥0.4 to exclude peripheral tracts and min-
imize partial voluming. Finally, each participant's aligned FA images
were projected onto the mean FA skeleton, and the resulting data
were fed into voxelwise permutation-based analysis.
2.8. Region of interest TBSS
To test for regional speciﬁc FA alterations, we ﬁrst implemented a
ROI-based TBSS. A binary mask encompassing the bilateral cingulate
cingulum, the bilateral hippocampal cingulum, the corpus callosum,
and the bilateral uncinate fasciculus was created as a ROI using the
Johns Hopkins University (JHU) White Matter Atlas provided by FSL
(Mori et al., 2005). The mask was then applied to the mean FA skeleton
in order to include only voxels comprised in themean FA skeleton. This
conﬁnes the statistical analysis exclusively to voxels from the center of
the tract, thereby minimizing anatomic inter-subject variability,
registration errors, and partial voluming. The resulting study-speciﬁc
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permutation-based ROI analysis.
2.9. Statistical analysis
Using FSL's Randomise Tool, permutation-based inferences with
threshold-free cluster enhancement (TFCE) were carried out for
voxelwise analysis of FA data (Smith and Nichols, 2009). In both the
ROI analysis and the whole brain analysis 5000 random permutations
were generated to build up the null distribution of the cluster size statis-
tic, while testing the following contrasts: 1) controls b patients and 2)
controls N patients. Age, gender and education (demeaned across
groups) were included in the analysis as nuisance regressors to correct
for between group variances. The resulting statistical maps were
corrected for multiple comparisons (p b 0.05, TFCE corrected), and the
JHU (John Hopkins University) White Matter and Juelich Histological
atlases were used to label clusters with signiﬁcant FA alterations.
2.10. Post-hoc analyses
In the patient group, the association between FA abnormalities and
psychological and clinical characteristics was examined using a voxel-
wise correlation approach. Clinical characteristics (disease duration in
years, duration of remission in years, and CSI scores), and scores on psy-
chological measures found to be signiﬁcantly different between the pa-
tients and the controls (MADRS and AS scores), were fed into FSL's
Randomise Tool along with the FA values of the voxels within regions
of signiﬁcant group differences resulting from the ROI analysis.
A mask was created of the voxels that were found to differ signiﬁ-
cantly between groups on FA resulting from the exploratory whole
brain analysis. Along with this mask, information on each individuals'
AD (the 1st eigenvalue), RD (the average of the 2nd and 3rd eigen-
values), and MD was fed into FSL's Randomise Tool using permuta-
tion-based inferences with TFCE.
3. Results
3.1. Psychometric data
At the day of theMRI scan, patients were asked about a lifetime his-
tory of psychiatric disorders. None of the patients reported any. Because
of the subjective nature of this information, we also inspected their
medical records and found no indications for the presence of psychiatric
disorders prior to the onset of Cushing's disease.Table 2
Symptom severity scores patients with long-term remission of Cushing's disease versus match
Patients with long-ter
Montgomery–Åsberg Depression Rating Scale (MADRS), mean (S.D.) 6.09 (5.71)
Inventory Depression Scale (IDS), mean (S.D.) 45.67 (12.99)
Beck Anxiety Inventory (BAI), mean (S.D.) 27.95 (5.65)
Fear Questionnaire (FQ), mean (S.D.) 23.76 (16.60)
Agoraphobia subscale, mean (S.D.) 4.90 (6.26)
Blood injury phobia subscale, mean (S.D.) 6.71 (8.75)
Social phobia subscale, mean (S.D.) 12.14 (7.88)
Irritability Scale (IS), mean (S.D.) 11.76 (9.17)
Apathy Scale (AS), mean (S.D.) 13.62 (6.70)
Cognitive Failure Questionnaire, mean (S.D.) 35.19 (14.57)
Motion parameters in millimeters
Absolute displacement, mean (S.D.) 1.67 (.367)
Relative displacement, mean (S.D.) .640 (.082)
S.D.= standard deviation. Due tomultiple comparisons, level of signiﬁcance was adjusted to p
signiﬁcant.
a Mann–Whitney U test.
b Independent sample t-test.The psychometric data are reported in Table 2. To correct for multi-
ple comparisons we applied a Bonferroni correction and adjusted the
level of signiﬁcance to p b .005. Comparisons on the psychometric
data between patients with long-term remission of Cushing's disease
and the matched healthy controls showed signiﬁcant differences on
the MADRS (p b .001) and on the AS (p= .003). No further signiﬁcant
differences were found between patients and controls. Within the
patient group we found no signiﬁcant correlation between age and
age of onset (p= .510), and age and disease duration (p= .057).3.2. TBSS analysis
Motion parameters (Table 2) did not differ signiﬁcantly between
groups for both absolute displacement (p= .078) and relative displace-
ment (p= .146). The TBSS ROI analysis showed signiﬁcant reductions
(p b .05, TFCE corrected) of FA values in patients compared to controls
in 8394 voxels of the 12,357 voxels that comprised the ROI study spe-
ciﬁc mask (67.9%). Regions that were found to have smaller FA values
in patients are the corpus callosum, the bilateral cingulate cingulum,
and the bilateral uncinate fasciculus (Fig. 1). No signiﬁcant differences
in FA values were observed in the bilateral hippocampal cingulum.
Using a voxel-wise correlation approach, we examined the associa-
tion between the observed smaller FA values, and psychological mea-
surements and clinical characteristics in the patient group. This was
conducted within the patient group by correlating the FA values of the
voxels that were observed in the between-group difference with the
scores on psychological measures. Because patients scored signiﬁcantly
higher on the MADRS and the AS, these were tested in addition to dis-
ease duration, duration of remission, and CSI scores (active phase and
remission phase). To correct for multiple comparisons we applied a
Bonferroni correction and adjusted the signiﬁcance level to p b .0083.
MADRS scores in the patient group correlated negativelywith FA values
in the left uncinate fasciculus (Fig. 2). We found no signiﬁcant correla-
tions in the patient group between FA values and AS scores, disease du-
ration, duration of remission, and CSI scores.
The exploratory whole brain analysis showedmultiple reductions of
FA values (p b .05, TFCE corrected) in various white matter tracts
throughout the brain in patients compared to controls (Fig. 3).
31,343 voxels of the 56,976 voxels that comprised the study-speciﬁc
whole brain mask were found to have signiﬁcantly smaller FA values
in patients (55%). Lowering the threshold (p b .1, TFCE corrected) result-
ed in the same pattern of reductions although slightly expanded. Tracts
that were not found to differ signiﬁcantly include: the inferior parts of
the brainstem, thewhitematter in the bilateral cerebellum, the bilateraled healthy controls.
m remission of Cushing's disease (n = 22) Matched healthy controls (n = 22) p
1.45 (1.84) .000a
36.14 (6.10) .020a
24.18 (3.20) .020a
14.36 (10.04) .033b
2.82 (3.43) .495a
3.55 (4.28) .334a
8.00 (4.97) .048b
8.73 (6.22) .342a
8.23 (3.77) .003b
29.36 (8.68) .123b
1.54 (.345) .078a
.597 (.111) .146b
b .005 using Bonferroni correction. Displayed in bold are the p-values that are considered
Fig. 1. Region-of-interest analysis results. (A) Three-dimensional renderings showing (from left to right) anterior, top, and posterior views of the white matter skeleton (green) of the
bilateral cingulate cingulum, the bilateral hippocampal cingulum, the corpus callosum, and the bilateral uncinate fasciculus. Superimposed in red are the regions in which FA values
are signiﬁcantly smaller in patients with long-term remission of Cushing's disease compared to matched healthy controls. (B) Coronal, sagittal and transversal axial sections of the
white matter skeleton (green; 12,357 voxels) superimposed on the FMRIB58_FA_1mm standard brain (gray). Depicted in red are the regions in which FA values are signiﬁcantly smaller
in patients with long-term remission of Cushing's disease compared to matched healthy controls (8394 voxels). All TBSS results are corrected for multiple comparisons (p b 0.05, TFCE
corrected), and the axial images are in radiological convention (the right side of the image corresponds with the left hemisphere of the brain and vice-versa). (C) Plots depicting the
mean FA value per group in the signiﬁcant ROIs. From left to right, the ﬁrst plot shows FA values in the right uncinate fasciculus (blue) and left uncinate fasciculus (green). The second
plot shows FA values in the right cingulate cingulum (blue) and left cingulate cingulum (green). The third plot shows the mean FA values in the corpus callosum.
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Fig. 2. Voxel-wise correlation between MADRS scores and FA values in patients with long-term remission of Cushing's disease. Voxel-wise correlation between MADRS scores and FA
values in patients with long-term remission of Cushing's disease. (A) Three-dimensional renderings showing (from left to right) anterior and left side views of the white matter skeleton
(green) of areas that differed between groups in the ROI analysis. FA values in the left uncinate fasciculus correlated negatively with MADRS scores (p b .0083) in the patients with long-
term remission of Cushing's disease (red). (B) Coronal, sagittal and transversal axial sections of thewhite matter skeleton (green) superimposed on the FMRIB58_FA_1mm standard brain
(gray). FA values in the left uncinate fasciculus correlated negatively with MADRS scores (p b .0083) in the patients with long-term remission of Cushing's disease (yellow). For better
visibility, the results are thickened using the “tbss-ﬁll” command (red). The axial images are in radiological convention (the right side of the image corresponds with the left hemisphere
of the brain and vice-versa). (C) A scatterplot showing the negative correlation between the mean FA in the left uncinate fasciculus and the scores on the MADRS in the patient group.
664 S.J.A. van der Werff et al. / NeuroImage: Clinical 4 (2014) 659–667hippocampal cingulum, the left inferior fronto-occipital fasciculus, and
parts of the bilateral superior longitudinal fasciculus.
Post-hoc analyses of the AD, RD, and MD in the voxels that showed
decreased FA between groups revealed a signiﬁcant increase (p b .05,
TFCE corrected) of RD and MD in the patient group compared to
controls. No signiﬁcant differences were found between groups in AD.
4. Discussion
Using a ROI approach, we found reduced white matter integrity in
patients compared to controls in the corpus callosum, the bilateral
cingulate cingulum, and the bilateral uncinate fasciculus, but not in
the bilateral hippocampal cingulum. The explorative whole brain
analysis showed widespread reductions of white matter integrity
throughout the brain. In the examined regions, we observed increasedRD and MD, as well as no differences in AD. Furthermore, we found
that FA values in the left uncinate fasciculus correlatedwith the severity
of depressive symptoms in the patients.
Our ROI analysis showed decreased FA in most of the hypothesized
regions in patients. However, the exploratory whole brain analysis
showed reductions of FA values in nearly all white matter tracts
throughout the brain. This leads to the idea that a general, white
matter-affecting mechanism underlies the observed differences
between patients and controls. Due to the cross-sectional design of
this study no causal conclusions can be drawn about the relation
between FA reductions and the reported psychopathology (i.e. depres-
sive symptoms, apathy). However, since all patients had a history of
hypercortisolism, we suggest that prolonged exposure to high levels
of cortisol has directly or indirectly affected the white matter tissue in
patients with Cushing's disease. Data from animal studies seem to
Fig. 3. Exploratory whole brain analysis results. Whole brain TBSS results. (A) Three-dimensional renderings showing (from left to right) anterior, top, and posterior views of the white
matter skeleton (green). Superimposed in red are the regions inwhich FA values are signiﬁcantly smaller in patients with long-term remission of Cushing's disease compared tomatched
healthy controls. (B) Coronal, sagittal and transversal axial sections of the white matter skeleton (green; 56,976 voxels) superimposed on the FMRIB58_FA_1mm standard brain (gray).
Depicted in red are the regions in which FA values are signiﬁcantly smaller in patients with long-term remission of Cushing's disease compared to matched healthy controls
(31,343 voxels). All TBSS results are corrected for multiple comparisons (p b 0.05, TFCE corrected), and the axial images are in radiological convention (the right side of the image
corresponds with the left hemisphere of the brain and vice-versa). (C) A plot of the mean FA value per group in the signiﬁcant effect found in the whole brain analysis.
665S.J.A. van der Werff et al. / NeuroImage: Clinical 4 (2014) 659–667support this suggestion. White matter mRNA expression (likely
reﬂecting oligodendrocytes responses) responds strongly and acutely
to corticosterone treatment (van Gemert et al., 2006). Prolonged expo-
sure to corticosteroids was associated with the inhibition ofproliferation of oligodendrocyte precursors throughout the white mat-
ter (Alonso, 2000). A more direct link with the lower FA values that
we observed in patients, is the ﬁnding that corticosterone in mice can
lead to an increased distance between nerve ﬁbers in ﬁber tracts as a
666 S.J.A. van der Werff et al. / NeuroImage: Clinical 4 (2014) 659–667consequence of direct glucocorticoid receptor activation in oligoden-
drocytes leading to increased branching of these cells and perhaps
lower levels of myelination. This is in line with our ﬁndings of increases
in RD, which has been related to demyelination and dysmyelination
(Alexander et al., 2007; Song et al., 2005). The increased MD we found
in the patient group is also an indication for decreased demyelination
(Horsﬁeld and Jones, 2002), but could also indicate the presence of
edema (Alexander et al., 2007).
In humans, direct effects of exposure to extreme levels of cortisol on
white matter integrity have never been studied. However, Johansson
et al. (2012) found that long-standing psychological distress in midlife
increases the risk of white matter lesions (Johansson et al., 2012). Addi-
tionally, it has been found that a speciﬁc genotype (ER22/23EK) related
to glucocorticoid resistance is associated with lower presence and pro-
gression of white matter lesions in dementia (van Rossum et al.,
2008). These results and the ﬁndings from our study, support the hy-
pothesis of prolonged elevated cortisol levels affecting white matter in
the brain in a non-localizedmanner. Longitudinal research should eluci-
date the mechanisms of the lasting effects of extreme levels of cortisol
on white matter integrity.
Our data may also point at a neural substrate for the persistence of
affective symptomatology in patients with Cushing's disease after treat-
ment for hypercortisolism (Tiemensma et al., 2010a). Using a voxel-
wise correlation approach,we found an association between depressive
symptom severity, as measured on the MADRS, and decreases in FA
values in the left uncinate fasciculus in patients. Recent studies in pa-
tients with depressive disorder also found decreased FA values in the
uncinate fasciculus (Carballedo et al., 2012; Taylor et al., 2007). The un-
cinate fasciculus passes from the rostral part of the temporal lobe (later-
al to the amygdala) and the insula, through the orbital and medial
frontal cortices (Kier et al., 2004; Schmahmann et al., 2008). This
white matter bundle effectively connects the limbic system with the
frontal regions of the brain and is an important connection in the emo-
tion regulation and stress network (Ghashghaei and Barbas, 2002).
In a previous study from our group, it was demonstrated that pa-
tients with long-term remission of Cushing's disease demonstrate
subtle cognitive impairments (Tiemensma et al., 2010b). In the pres-
ent study no differences were found using the CFQ. Although the CFQ
is a validated and commonly used questionnaire, it is not equal to ex-
tensive neuropsychological testing that would provide a more accu-
rate assessment of cognitive functioning. It might be that the CFQ
was not sensitive enough to detect these subtle impairments. 12 pa-
tients remained hydrocortisone dependent after treatment for
Cushing's disease. We did not ﬁnd differences in FA values between
patient with and without hydrocortisone substitution (data not
shown), suggesting that our results were not driven by hydrocorti-
sone dependence. Due to the gradual onset of the a-speciﬁc symp-
toms of Cushing's disease, and the high prevalence of psychiatric
symptomatology in Cushing's disease it is difﬁcult to make a clear
distinction between Cushing's related psychiatric symptoms and in-
dependently developed psychiatric symptoms. Therefore, it is possi-
ble that psychiatric symptomatology in the patients developed
independently or prior to the onset of Cushing's disease.
The data presented in this study provide a further perspective to-
wards a detailed phenotyping of patients after the treatment of
Cushing's disease, who often report persisting psychological symptom-
atology and cognitive impairment. It is tempting to speculate that our
ﬁndings, to a certain extent, could also apply to patients with chronic
or recurrent forms of highly prevalent stress-related disorders such as
depression, and, in addition, to patients treatedwith exogenous cortico-
steroids that are commonly prescribed to suppress the immune system
(Brown and Suppes, 1998).
This study is the ﬁrst to demonstrate that white matter integrity is
affected in patients treated for Cushing's disease, despite long-term re-
mission of cortisol excess. More research is needed to elucidate the
role of cortisol in affecting white matter tissue integrity and the cellularmechanisms that underlie this process. Furthermore, it should be clari-
ﬁed as to how abnormalities in structural connectivity interact with po-
tential differences in functional connectivity and how this interaction
relates to the psychological symptomatology observed in patients
with remission of Cushing's disease.
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